Ra Capital Management as of Dec. 31, 2020
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 82 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S Sponsored Adr (ASND) | 13.7 | $978M | 5.9M | 166.78 | |
| Tg Therapeutics (TGTX) | 6.3 | $452M | 8.7M | 52.02 | |
| Novavax Com New (NVAX) | 5.9 | $423M | 3.8M | 111.51 | |
| Nkarta (NKTX) | 4.8 | $345M | 5.6M | 61.47 | |
| Forma Therapeutics Hldgs SHS | 4.4 | $315M | 9.0M | 34.90 | |
| Arvinas Ord (ARVN) | 4.4 | $312M | 3.7M | 84.93 | |
| Chemocentryx | 4.1 | $296M | 4.8M | 61.92 | |
| Atea Pharmaceuticals (AVIR) | 3.1 | $224M | 5.4M | 41.78 | |
| Iteos Therapeutics (ITOS) | 2.1 | $149M | 4.4M | 33.82 | |
| Kinnate Biopharma | 2.0 | $143M | 3.6M | 39.78 | |
| Axsome Therapeutics (AXSM) | 1.9 | $135M | 1.7M | 81.47 | |
| Keros Therapeutics (KROS) | 1.8 | $132M | 1.9M | 70.54 | |
| Phathom Pharmaceuticals (PHAT) | 1.8 | $127M | 3.8M | 33.22 | |
| Rhythm Pharmaceuticals (RYTM) | 1.7 | $124M | 4.2M | 29.73 | |
| Travere Therapeutics (TVTX) | 1.7 | $124M | 4.6M | 27.26 | |
| ImmunoGen | 1.7 | $119M | 18M | 6.45 | |
| Rocket Pharmaceuticals (RCKT) | 1.6 | $117M | 2.1M | 54.84 | |
| 89bio (ETNB) | 1.6 | $115M | 4.7M | 24.37 | |
| Zogenix Com New | 1.5 | $107M | 5.3M | 19.99 | |
| Pmv Pharmaceuticals (PMVP) | 1.5 | $105M | 1.7M | 61.51 | |
| Olema Pharmaceuticals (OLMA) | 1.4 | $103M | 2.2M | 48.08 | |
| Adverum Biotechnologies | 1.4 | $103M | 9.5M | 10.84 | |
| Macrogenics (MGNX) | 1.4 | $100M | 4.4M | 22.86 | |
| Vaxcyte (PCVX) | 1.4 | $99M | 3.7M | 26.57 | |
| Igm Biosciences (IGMS) | 1.2 | $87M | 983k | 88.29 | |
| Black Diamond Therapeutics (BDTX) | 1.2 | $83M | 2.6M | 32.05 | |
| Silverback Therapeutics (SPRY) | 1.1 | $81M | 1.7M | 46.34 | |
| Trillium Therapeutics Com New | 1.1 | $78M | 5.3M | 14.71 | |
| Solid Biosciences | 1.1 | $76M | 10M | 7.58 | |
| Kala Pharmaceuticals | 1.0 | $74M | 11M | 6.78 | |
| Five Prime Therapeutics | 1.0 | $73M | 4.3M | 17.01 | |
| Inhibrx | 1.0 | $70M | 2.1M | 32.97 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.9 | $68M | 2.4M | 28.16 | |
| Curis Com New | 0.9 | $63M | 7.7M | 8.19 | |
| Wave Life Sciences SHS (WVE) | 0.9 | $61M | 7.8M | 7.87 | |
| Cardiff Oncology (CRDF) | 0.8 | $59M | 3.3M | 17.99 | |
| Dyne Therapeutics (DYN) | 0.8 | $59M | 2.8M | 21.00 | |
| Constellation Pharmceticls I | 0.7 | $53M | 1.9M | 28.80 | |
| Pacific Biosciences of California (PACB) | 0.7 | $52M | 2.0M | 25.94 | |
| Geron Corporation (GERN) | 0.7 | $48M | 30M | 1.59 | |
| Sutro Biopharma (STRO) | 0.6 | $46M | 2.1M | 21.71 | |
| C4 Therapeutics Com Stk (CCCC) | 0.6 | $46M | 1.4M | 33.13 | |
| Akouos | 0.6 | $45M | 2.3M | 19.83 | |
| Relay Therapeutics (RLAY) | 0.6 | $42M | 1.0M | 41.56 | |
| Inozyme Pharma (INZY) | 0.6 | $41M | 2.0M | 20.64 | |
| Orchard Therapeutics Ads | 0.6 | $41M | 12M | 3.34 | |
| Ardelyx (ARDX) | 0.6 | $40M | 6.2M | 6.47 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.5 | $37M | 2.2M | 16.58 | |
| Arcutis Biotherapeutics (ARQT) | 0.5 | $33M | 1.2M | 28.13 | |
| Larimar Therapeutics (LRMR) | 0.5 | $32M | 1.5M | 21.41 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.4 | $32M | 5.1M | 6.24 | |
| Pandion Therapeutics | 0.4 | $26M | 1.8M | 14.85 | |
| Alector (ALEC) | 0.3 | $25M | 1.6M | 15.13 | |
| Concert Pharmaceuticals I equity | 0.3 | $23M | 1.8M | 12.64 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $23M | 1.0M | 22.24 | |
| Satsuma Pharmaceuticals Ord | 0.3 | $22M | 4.7M | 4.61 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $20M | 584k | 33.85 | |
| Scpharmaceuticals (SCPH) | 0.3 | $19M | 3.5M | 5.29 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.2 | $16M | 1.3M | 12.20 | |
| Vaxart Com New (VXRT) | 0.2 | $16M | 2.7M | 5.71 | |
| Milestone Pharmaceuticals (MIST) | 0.2 | $16M | 2.3M | 6.70 | |
| Ocular Therapeutix (OCUL) | 0.2 | $16M | 750k | 20.70 | |
| Bctg Acquisition Corp | 0.2 | $14M | 1.3M | 11.44 | |
| Repare Therapeutics Ord (RPTX) | 0.2 | $14M | 409k | 34.30 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $14M | 1.3M | 11.14 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $14M | 2.5M | 5.39 | |
| Cogent Biosciences (COGT) | 0.2 | $12M | 1.0M | 11.23 | |
| Arya Sciences Acquisition Com Cl A | 0.2 | $11M | 1.0M | 10.85 | |
| Frazier Lifesciences Acquisition Unit 12/09/2025 | 0.1 | $10M | 1.0M | 10.38 | |
| Therapeuticsmd | 0.1 | $9.5M | 7.8M | 1.21 | |
| Lyra Therapeutics (LYRA) | 0.1 | $9.3M | 816k | 11.40 | |
| Passage Bio (PASG) | 0.1 | $8.3M | 323k | 25.57 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $8.0M | 625k | 12.81 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $8.0M | 564k | 14.11 | |
| Helix Acquisition Corp Com Cl A | 0.1 | $8.0M | 700k | 11.37 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $7.6M | 750k | 10.17 | |
| Miragen Therapeutics Com New | 0.1 | $7.4M | 452k | 16.45 | |
| Imara | 0.1 | $5.5M | 249k | 22.05 | |
| Profound Medical Corp Com New (PROF) | 0.1 | $4.0M | 192k | 20.56 | |
| X4 Pharmaceuticals (XFOR) | 0.0 | $3.5M | 537k | 6.43 | |
| Cerevel Therapeutics Hldng *w Exp 06/09/2027 (CEREW) | 0.0 | $1.3M | 233k | 5.65 | |
| Ovid Therapeutics (OVID) | 0.0 | $658k | 285k | 2.31 |
